These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1111 related items for PubMed ID: 9925076

  • 1. Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer.
    Pujol JL, Lafontaine T, Quantin X, Reme-Saumon M, Cupissol D, Khial F, Michel FB.
    Chest; 1999 Jan; 115(1):144-50. PubMed ID: 9925076
    [Abstract] [Full Text] [Related]

  • 2. Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancer.
    Fetscher S, Brugger W, Engelhardt R, Kanz L, Hasse J, Frommhold H, Wenger M, Lange W, Mertelsmann R.
    Ann Oncol; 1997 Jan; 8(1):57-64. PubMed ID: 9093708
    [Abstract] [Full Text] [Related]

  • 3. Long-term results of neoadjuvant ifosfamide, cisplatin, and etoposide combination in locally advanced non-small-cell lung cancer.
    Pujol JL, Hayot M, Rouanet P, Le Chevalier T, Michel FB.
    Chest; 1994 Nov; 106(5):1451-5. PubMed ID: 7956400
    [Abstract] [Full Text] [Related]

  • 4. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E, Silvano G, Tibaldi C, Campoccia S, Cionini L, Conte P.
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [Abstract] [Full Text] [Related]

  • 5. Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung cancer.
    Kalemkerian GP, Belzer K, Wozniak AJ, Gaspar LE, Valdivieso M, Kraut MJ.
    Lung Cancer; 1999 Sep; 25(3):175-82. PubMed ID: 10512128
    [Abstract] [Full Text] [Related]

  • 6. Sequential treatment with vindesine-ifosfamide-platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: a phase II trial.
    Van den Brande P, De Ruysscher D, Vansteenkiste J, Spaas P, Specenier P, Demedts M.
    Lung Cancer; 1998 Oct; 22(1):45-53. PubMed ID: 9869107
    [Abstract] [Full Text] [Related]

  • 7. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
    Vokes EE, Haraf DJ, Drinkard LC, Hoffman PC, Ferguson MK, Vogelzang NJ, Watson S, Lane NJ, Golomb HM.
    Cancer Chemother Pharmacol; 1995 Oct; 35(4):304-12. PubMed ID: 7530173
    [Abstract] [Full Text] [Related]

  • 8. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.
    Reboul F, Brewer Y, Vincent P, Chauvet B, Faure CF, Taulelle M.
    Int J Radiat Oncol Biol Phys; 1996 May 01; 35(2):343-50. PubMed ID: 8635942
    [Abstract] [Full Text] [Related]

  • 9. Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study.
    Hazuka MB, Crowley JJ, Bunn PA, O'Rourke M, Braun TJ, Livingston RB.
    J Clin Oncol; 1994 Sep 01; 12(9):1814-20. PubMed ID: 8083705
    [Abstract] [Full Text] [Related]

  • 10. Results of a phase II concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage III nonsmall-cell lung cancer.
    Chen LM, Ignacio L, Jacobs R, Kozloff M, Telfer M, Elahi R, Evans R, Vijayakumar S.
    Radiat Oncol Investig; 1999 Sep 01; 7(1):49-53. PubMed ID: 10030624
    [Abstract] [Full Text] [Related]

  • 11. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
    Zwitter M, Kovac V, Smrdel U, Strojan P.
    J Thorac Oncol; 2006 Sep 01; 1(7):662-6. PubMed ID: 17409933
    [Abstract] [Full Text] [Related]

  • 12. A pilot study of protracted low dose cisplatin and etoposide with concurrent thoracic radiotherapy in unresectable stage III nonsmall cell lung cancer.
    Blanke C, DeVore R, Shyr Y, Epstein B, Murray M, Hande K, Stewart S, Johnson D.
    Int J Radiat Oncol Biol Phys; 1997 Jan 01; 37(1):111-6. PubMed ID: 9054884
    [Abstract] [Full Text] [Related]

  • 13. Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer.
    Scagliotti GV, Ricardi U, Crinó L, Maranzano E, De Marinis F, Morandi MG, Meacci L, Marangolo M, Emiliani E, Rosti G, Figoli F, Bolzicco G, Masiero P, Gentile A, Tonato M.
    Cancer Chemother Pharmacol; 1996 Jan 01; 38(6):561-5. PubMed ID: 8823499
    [Abstract] [Full Text] [Related]

  • 14. r-metHuG-CSF support to ifosfamide, cisplatin, etoposide chemotherapy in non-small cell lung cancer.
    Gautier V, Pujol JL, Zinaï A, Michel FB.
    Lung Cancer; 1996 Jun 01; 14(2-3):343-51. PubMed ID: 8794415
    [Abstract] [Full Text] [Related]

  • 15. Induction chemotherapy followed by concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer.
    Tan EH, Wee J, Ang PT, Fong KW, Leong SS, Khoo KS, Tan T, Lee KS, Eng P, Hsu A, Tan YK, Chua EJ, Ong YY.
    Acta Oncol; 1999 Jun 01; 38(8):1005-9. PubMed ID: 10665753
    [Abstract] [Full Text] [Related]

  • 16. Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer.
    Shepherd FA, Evans WK, Goss PE, Latreille J, Logan D, Maroun J, Stewart D, Warner E, Paul K.
    Semin Oncol; 1992 Feb 01; 19(1 Suppl 1):54-8. PubMed ID: 1329213
    [Abstract] [Full Text] [Related]

  • 17. Paclitaxel in combination chemotherapy with radiotherapy in patients with unresectable stage III non-small-cell lung cancer.
    Greco FA, Stroup SL, Gray JR, Hainsworth JD.
    J Clin Oncol; 1996 May 01; 14(5):1642-8. PubMed ID: 8622083
    [Abstract] [Full Text] [Related]

  • 18. Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
    Krzakowski M, Provencio M, Utracka-Hutka B, Villa E, Codes M, Kuten A, Henke M, Lopez M, Bell D, Biti G, Merimsky O, Beorchia A, Riggi M, Caux NR, Pouget JC, Dubray B, David P.
    J Thorac Oncol; 2008 Sep 01; 3(9):994-1002. PubMed ID: 18758302
    [Abstract] [Full Text] [Related]

  • 19. Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb): a pilot phase I/II trial.
    Pöttgen C, Eberhardt W, Bildat S, Stüben G, Stamatis G, Hillejan L, Sohrab S, Teschler H, Seeber S, Sack H, Stuschke M.
    Ann Oncol; 2002 Mar 01; 13(3):403-11. PubMed ID: 11996471
    [Abstract] [Full Text] [Related]

  • 20. Alternating chemotherapy and accelerated split-course irradiation in locally advanced nonsmall cell lung carcinoma.
    Pignon T, Ruggieri S, Boutin C, Gouvernet J, Irisson M, Juin P, Astoul P.
    Cancer; 1999 May 15; 85(10):2144-50. PubMed ID: 10326692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.